OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
13
Results
Show all
Save search
Copy query
Show results for
Unknown
(13)
Publication Date
Release Date
2022
(4)
2023
(3)
2018
(2)
2016
(2)
2025
(1)
2021
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Individualized therapy for persistent asthma in young children.
Not available
S-EPMC5148729
|
biostudies-literature
Cite
Acetaminophen versus Ibuprofen in Young Children with Mild Persistent Asthma.
Not available
S-EPMC5085065
|
biostudies-literature
Cite
Ongoing declines for the world's amphibians in the face of emerging threats.
Not available
S-EPMC10567568
|
biostudies-literature
Cite
Glutathione and arginine levels: Predictors for acetaminophen-associated asthma exacerbation?
Not available
S-EPMC6035773
|
biostudies-literature
Cite
Quintupling Inhaled Glucocorticoids to Prevent Childhood Asthma Exacerbations.
Not available
S-EPMC5972517
|
biostudies-literature
Cite
Implicating genes, pleiotropy, and sexual dimorphism at blood lipid loci through multi-ancestry meta-analysis.
Not available
S-EPMC9793579
|
biostudies-literature
Cite
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial.
Not available
S-EPMC8121538
|
biostudies-literature
Cite
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.
Not available
S-EPMC9333998
|
biostudies-literature
Cite
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8830904
|
biostudies-literature
Cite
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC10957483
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets